Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
0(0%)
Results Posted
25%(2 trials)

Phase Distribution

Ph phase_4
4
44%
Ph phase_2
1
11%
Ph phase_3
4
44%

Phase Distribution

0

Early Stage

1

Mid Stage

8

Late Stage

Phase Distribution9 total trials
Phase 2Efficacy & side effects
1(11.1%)
Phase 3Large-scale testing
4(44.4%)
Phase 4Post-market surveillance
4(44.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Completed(8)
Terminated(1)

Detailed Status

Completed8
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (11.1%)
Phase 34 (44.4%)
Phase 44 (44.4%)

Trials by Status

withdrawn111%
completed889%

Recent Activity

0 active trials
Showing 5 of 9
completedphase_3

Efficacy and Safety Study of a Steroid/Antibiotic Combination Eyedrop to Treat Non-Bacterial Blepharitis

NCT01408082
withdrawnphase_2

Study to Determine the Effect of Azasite on Corneal Surface Irregularity

NCT01797107
completedphase_3

Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Tobramycin for Bacterial Conjunctivitis (C-01-401-004)

NCT00105469
completedphase_3

Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Vehicle for Bacterial Conjunctivitis (C-01-401-003)

NCT00105534
completedphase_3

A Study to Evaluate the Clinical Efficacy and Safety of Tobradex® ST Compared to Azasite® in the Treatment of Subjects With Moderate to Severe Chronic Blepharitis

NCT01102244
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT01408082Phase 3

Efficacy and Safety Study of a Steroid/Antibiotic Combination Eyedrop to Treat Non-Bacterial Blepharitis

Completed
NCT01797107Phase 2

Study to Determine the Effect of Azasite on Corneal Surface Irregularity

Withdrawn
NCT00105469Phase 3

Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Tobramycin for Bacterial Conjunctivitis (C-01-401-004)

Completed
NCT00105534Phase 3

Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Vehicle for Bacterial Conjunctivitis (C-01-401-003)

Completed
NCT01102244Phase 3

A Study to Evaluate the Clinical Efficacy and Safety of Tobradex® ST Compared to Azasite® in the Treatment of Subjects With Moderate to Severe Chronic Blepharitis

Completed
NCT00629980Phase 4

Safety and Efficacy Pilot Study of AzaSite® (Azithromycin) in Subjects With Blepharitis

Completed
NCT00656539Phase 4

Safety and Efficacy Pilot Study of AzaSite® for Four Weeks in Subjects With Blepharitis

Completed
NCT00629941Phase 4

Safety and Efficacy Study of AzaSite® in Subjects With Blepharitis

Completed
NCT00629590Phase 4

Safety and Efficacy Pilot Study of AzaSite (Azithromycin) in Subjects With Blepharitis

Completed

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9